[English] 日本語
Yorodumi
- PDB-5q0j: Ligand binding to FARNESOID-X-RECEPTOR -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 5q0j
TitleLigand binding to FARNESOID-X-RECEPTOR
Components
  • Bile acid receptor
  • COACTIVATOR PEPTIDE SRC-1 HD3
KeywordsTRANSCRIPTION / D3R / FXR / Docking
Function / homology
Function and homology information


chenodeoxycholic acid binding / positive regulation of phosphatidic acid biosynthetic process / positive regulation of ammonia assimilation cycle / regulation of low-density lipoprotein particle clearance / : / cellular response to bile acid / intracellular triglyceride homeostasis / urea metabolic process / negative regulation of interleukin-1 production / negative regulation of very-low-density lipoprotein particle remodeling ...chenodeoxycholic acid binding / positive regulation of phosphatidic acid biosynthetic process / positive regulation of ammonia assimilation cycle / regulation of low-density lipoprotein particle clearance / : / cellular response to bile acid / intracellular triglyceride homeostasis / urea metabolic process / negative regulation of interleukin-1 production / negative regulation of very-low-density lipoprotein particle remodeling / regulation of insulin secretion involved in cellular response to glucose stimulus / regulation of bile acid biosynthetic process / negative regulation of monocyte chemotactic protein-1 production / toll-like receptor 9 signaling pathway / nuclear receptor-mediated bile acid signaling pathway / bile acid nuclear receptor activity / labyrinthine layer morphogenesis / bile acid binding / regulation of thyroid hormone receptor signaling pathway / positive regulation of transcription from RNA polymerase II promoter by galactose / positive regulation of female receptivity / cellular response to fatty acid / cell-cell junction assembly / regulation of cholesterol metabolic process / negative regulation of interleukin-2 production / NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis / hypothalamus development / negative regulation of interleukin-6 production / bile acid and bile salt transport / male mating behavior / positive regulation of interleukin-17 production / negative regulation of type II interferon production / progesterone receptor signaling pathway / cellular response to Thyroglobulin triiodothyronine / Synthesis of bile acids and bile salts / negative regulation of tumor necrosis factor production / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / fatty acid homeostasis / Endogenous sterols / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / positive regulation of insulin receptor signaling pathway / response to retinoic acid / protein-lysine-acetyltransferase activity / negative regulation of tumor necrosis factor-mediated signaling pathway / nuclear retinoid X receptor binding / estrous cycle / Recycling of bile acids and salts / Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 / histone acetyltransferase / lactation / NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux / estrogen receptor signaling pathway / cellular response to hormone stimulus / intracellular receptor signaling pathway / peroxisome proliferator activated receptor signaling pathway / Regulation of lipid metabolism by PPARalpha / response to progesterone / cerebellum development / positive regulation of adipose tissue development / cholesterol homeostasis / positive regulation of neuron differentiation / BMAL1:CLOCK,NPAS2 activates circadian expression / regulation of cellular response to insulin stimulus / RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression / Activation of gene expression by SREBF (SREBP) / SUMOylation of transcription cofactors / Expression of BMAL (ARNTL), CLOCK, and NPAS2 / intracellular glucose homeostasis / nuclear estrogen receptor binding / nuclear receptor binding / hippocampus development / negative regulation of canonical NF-kappaB signal transduction / transcription coregulator binding / positive regulation of insulin secretion involved in cellular response to glucose stimulus / RNA polymerase II transcription regulatory region sequence-specific DNA binding / SUMOylation of intracellular receptors / Heme signaling / male gonad development / PPARA activates gene expression / Cytoprotection by HMOX1 / Transcriptional activation of mitochondrial biogenesis / euchromatin / cerebral cortex development / negative regulation of inflammatory response / Nuclear Receptor transcription pathway / Transcriptional regulation of white adipocyte differentiation / RNA polymerase II transcription regulator complex / mRNA transcription by RNA polymerase II / nuclear receptor activity / response to estradiol / HATs acetylate histones / cellular response to lipopolysaccharide / MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis / transcription regulator complex / DNA-binding transcription activator activity, RNA polymerase II-specific / Estrogen-dependent gene expression / sequence-specific DNA binding / DNA-binding transcription factor activity, RNA polymerase II-specific / cell differentiation / transcription coactivator activity
Similarity search - Function
Bile acid receptor, ligand binding domain / Thyroid hormone receptor / Nuclear receptor coactivator 1 / Nuclear receptor coactivator, DUF1518 / Nuclear receptor coactivator, Ncoa-type, interlocking / Nuclear receptor coactivator, Ncoa-type, interlocking domain superfamily / Nuclear receptor coactivator, DUF1518 / Nuclear receptor coactivator / DUF1518 / Nuclear receptor coactivator, receptor-binding domain ...Bile acid receptor, ligand binding domain / Thyroid hormone receptor / Nuclear receptor coactivator 1 / Nuclear receptor coactivator, DUF1518 / Nuclear receptor coactivator, Ncoa-type, interlocking / Nuclear receptor coactivator, Ncoa-type, interlocking domain superfamily / Nuclear receptor coactivator, DUF1518 / Nuclear receptor coactivator / DUF1518 / Nuclear receptor coactivator, receptor-binding domain / Nuclear receptor coactivator / : / Steroid receptor coactivator / Unstructured region on nuclear receptor coactivator protein / Nuclear receptor coactivators bHLH domain / PAS domain / Nuclear receptor coactivator, interlocking / helix loop helix domain / Myc-type, basic helix-loop-helix (bHLH) domain / Myc-type, basic helix-loop-helix (bHLH) domain profile. / Helix-loop-helix DNA-binding domain superfamily / : / PAS fold / PAS fold / PAS domain / PAS repeat profile. / PAS domain / Retinoid X Receptor / Retinoid X Receptor / PAS domain superfamily / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Double treble clef zinc finger, C4 type / Nuclear hormone receptors DNA-binding domain profile. / c4 zinc finger in nuclear hormone receptors / Nuclear hormone receptor, ligand-binding domain / Nuclear hormone receptor-like domain superfamily / Ligand-binding domain of nuclear hormone receptor / Nuclear receptor (NR) ligand-binding (LBD) domain profile. / Ligand binding domain of hormone receptors / Zinc finger, NHR/GATA-type / Orthogonal Bundle / Mainly Alpha
Similarity search - Domain/homology
Chem-9KV / Nuclear receptor coactivator / Nuclear receptor coactivator 1 / Bile acid receptor
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2 Å
Model detailsStructures re-refined for D3R docking challenge
AuthorsRudolph, M.G. / Benz, J. / Burger, D. / Thoma, R. / Ruf, A. / Joseph, C. / Kuhn, B. / Shao, C. / Yang, H. / Burley, S.K.
CitationJournal: J. Comput. Aided Mol. Des. / Year: 2018
Title: D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.
Authors: Gaieb, Z. / Liu, S. / Gathiaka, S. / Chiu, M. / Yang, H. / Shao, C. / Feher, V.A. / Walters, W.P. / Kuhn, B. / Rudolph, M.G. / Burley, S.K. / Gilson, M.K. / Amaro, R.E.
History
DepositionMay 31, 2017Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jul 5, 2017Provider: repository / Type: Initial release
Revision 1.1Jul 19, 2017Group: Database references / Structure summary / Category: audit_author / citation_author / Item: _audit_author.name / _citation_author.name
Revision 1.2Dec 20, 2017Group: Database references / Category: citation / citation_author
Item: _citation.journal_abbrev / _citation.journal_id_CSD ..._citation.journal_abbrev / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.3Jan 31, 2018Group: Database references / Category: citation
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.year
Revision 1.4Feb 21, 2018Group: Structure summary / Category: pdbx_deposit_group / Item: _pdbx_deposit_group.group_type
Revision 1.5Feb 10, 2021Group: Database references / Structure summary / Category: audit_author / citation / citation_author
Item: _audit_author.identifier_ORCID / _citation.country / _citation_author.identifier_ORCID
Revision 1.6Nov 17, 2021Group: Database references / Structure summary / Category: database_2 / pdbx_deposit_group
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_deposit_group.group_description
Revision 1.7Nov 6, 2024Group: Data collection / Refinement description / Structure summary
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / pdbx_entry_details / pdbx_modification_feature / struct_ncs_dom_lim
Item: _struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id ..._struct_ncs_dom_lim.beg_auth_comp_id / _struct_ncs_dom_lim.beg_label_asym_id / _struct_ncs_dom_lim.beg_label_comp_id / _struct_ncs_dom_lim.beg_label_seq_id / _struct_ncs_dom_lim.end_auth_comp_id / _struct_ncs_dom_lim.end_label_asym_id / _struct_ncs_dom_lim.end_label_comp_id / _struct_ncs_dom_lim.end_label_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Bile acid receptor
B: COACTIVATOR PEPTIDE SRC-1 HD3
C: Bile acid receptor
D: COACTIVATOR PEPTIDE SRC-1 HD3
hetero molecules


Theoretical massNumber of molelcules
Total (without water)58,7766
Polymers57,7804
Non-polymers9952
Water4,017223
1
A: Bile acid receptor
B: COACTIVATOR PEPTIDE SRC-1 HD3
hetero molecules


Theoretical massNumber of molelcules
Total (without water)29,3883
Polymers28,8902
Non-polymers4981
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area1110 Å2
ΔGint-6 kcal/mol
Surface area11970 Å2
MethodPISA
2
C: Bile acid receptor
D: COACTIVATOR PEPTIDE SRC-1 HD3
hetero molecules


Theoretical massNumber of molelcules
Total (without water)29,3883
Polymers28,8902
Non-polymers4981
Water362
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area1120 Å2
ΔGint-8 kcal/mol
Surface area11850 Å2
MethodPISA
Unit cell
Length a, b, c (Å)71.865, 84.076, 188.931
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number20
Space group name H-MC2221
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails (eV)
11(chain B and resid 746 through 755)
21chain D
12(chain A and (resid 248 through 331 or resid 333...
22(chain C and (resid 248 through 331 or resid 333...

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDSelection detailsAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
111HISHISLYSLYS(chain B and resid 746 through 755)BB746 - 7553 - 12
211HISHISLYSLYSchain DDD746 - 7553 - 12
112GLUGLUALAALA(chain A and (resid 248 through 331 or resid 333...AA248 - 3315 - 88
122PHEPHELEULEU(chain A and (resid 248 through 331 or resid 333...AA333 - 35290 - 109
132ALAALAARGARG(chain A and (resid 248 through 331 or resid 333...AA354 - 357111 - 114
142SERSERLYSLYS(chain A and (resid 248 through 331 or resid 333...AA359 - 374116 - 131
152ILEILELEULEU(chain A and (resid 248 through 331 or resid 333...AA376 - 395133 - 152
162PROPROASPASP(chain A and (resid 248 through 331 or resid 333...AA397 - 404154 - 161
172GLUGLUGLNGLN(chain A and (resid 248 through 331 or resid 333...AA406 - 412163 - 169
182PROPROILEILE(chain A and (resid 248 through 331 or resid 333...AA414 - 425171 - 182
192GLNGLNALAALA(chain A and (resid 248 through 331 or resid 333...AA427 - 435184 - 192
1102LEULEUTHRTHR(chain A and (resid 248 through 331 or resid 333...AA437 - 442194 - 199
1112LEULEUALAALA(chain A and (resid 248 through 331 or resid 333...AA444 - 452201 - 209
1122LEULEUTRPTRP(chain A and (resid 248 through 331 or resid 333...AA455 - 458212 - 215
1132VALVALGLNGLN(chain A and (resid 248 through 331 or resid 333...AA460 - 476217 - 233
212GLUGLUALAALA(chain C and (resid 248 through 331 or resid 333...CC248 - 3315 - 88
222PHEPHELEULEU(chain C and (resid 248 through 331 or resid 333...CC333 - 35290 - 109
232ALAALAARGARG(chain C and (resid 248 through 331 or resid 333...CC354 - 357111 - 114
242SERSERLYSLYS(chain C and (resid 248 through 331 or resid 333...CC359 - 374116 - 131
252ILEILELEULEU(chain C and (resid 248 through 331 or resid 333...CC376 - 395133 - 152
262PROPROASPASP(chain C and (resid 248 through 331 or resid 333...CC397 - 404154 - 161
272GLUGLUGLNGLN(chain C and (resid 248 through 331 or resid 333...CC406 - 412163 - 169
282PROPROILEILE(chain C and (resid 248 through 331 or resid 333...CC414 - 425171 - 182
292GLNGLNALAALA(chain C and (resid 248 through 331 or resid 333...CC427 - 435184 - 192
2102LEULEUTHRTHR(chain C and (resid 248 through 331 or resid 333...CC437 - 442194 - 199
2112LEULEUALAALA(chain C and (resid 248 through 331 or resid 333...CC444 - 452201 - 209
2122LEULEUTRPTRP(chain C and (resid 248 through 331 or resid 333...CC455 - 458212 - 215
2132VALVALGLNGLN(chain C and (resid 248 through 331 or resid 333...CC460 - 476217 - 233

NCS ensembles :
ID
1
2

-
Components

#1: Protein Bile acid receptor / Farnesoid X-activated receptor / Farnesol receptor HRR-1 / Nuclear receptor subfamily 1 group H ...Farnesoid X-activated receptor / Farnesol receptor HRR-1 / Nuclear receptor subfamily 1 group H member 4 / Retinoid X receptor-interacting protein 14 / RXR-interacting protein 14


Mass: 27100.191 Da / Num. of mol.: 2 / Fragment: UNP residues 258-486
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: NR1H4, BAR, FXR, HRR1, RIP14 / Plasmid: PET28A / Production host: Escherichia coli (E. coli) / References: UniProt: Q96RI1
#2: Protein/peptide COACTIVATOR PEPTIDE SRC-1 HD3


Mass: 1790.026 Da / Num. of mol.: 2 / Fragment: UNP residues 744-757 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) / References: UniProt: A8K1V4, UniProt: Q15788*PLUS
#3: Chemical ChemComp-9KV / (2S)-N,2-dicyclohexyl-2-[2-(5-phenylthiophen-2-yl)-1H-benzimidazol-1-yl]acetamide


Mass: 497.694 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C31H35N3OS
#4: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 223 / Source method: isolated from a natural source / Formula: H2O
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.52 Å3/Da / Density % sol: 51.13 %
Crystal growTemperature: 298 K / Method: evaporation, hanging drop / pH: 6.5
Details: 0.2 M Na Chloride, 0.1 M Bis-Tris pH 6.5, 25% w/v PEG 3350

-
Data collection

DiffractionMean temperature: 100 K
Diffraction sourceSource: SYNCHROTRON / Site: SLS / Beamline: X10SA / Wavelength: 1 Å
DetectorType: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Sep 27, 2006
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 2→38.4 Å / Num. all: 39139 / Num. obs: 38634 / % possible obs: 98.7 % / Redundancy: 0.99 % / Net I/σ(I): 13.46
Reflection shellResolution: 2→2.1 Å / Redundancy: 1 % / Num. possible: 5247 / Num. unique obs: 5241 / Net I/σ(I) obs: 2.24 / % possible all: 99.9

-
Phasing

PhasingMethod: molecular replacement

-
Processing

Software
NameVersionClassificationNB
PHENIXrefinement
HKL-2000data scaling
PDB_EXTRACT3.23data extraction
HKL-2000data reduction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 2→35.729 Å / SU ML: 0.28 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 26.29 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2471 1922 4.99 %
Rwork0.1945 36578 -
obs0.1972 38500 98.51 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 128.66 Å2 / Biso mean: 46.0839 Å2 / Biso min: 17.11 Å2
Refinement stepCycle: final / Resolution: 2→35.729 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms3949 0 83 223 4255
Biso mean--33.55 49.5 -
Num. residues----481
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.014231
X-RAY DIFFRACTIONf_angle_d1.3245739
X-RAY DIFFRACTIONf_chiral_restr0.062635
X-RAY DIFFRACTIONf_plane_restr0.009733
X-RAY DIFFRACTIONf_dihedral_angle_d10.0853543
Refine LS restraints NCS
Ens-IDDom-IDAuth asym-IDNumberRefine-IDRmsType
11B78X-RAY DIFFRACTION10.7TORSIONAL
12D78X-RAY DIFFRACTION10.7TORSIONAL
21A1962X-RAY DIFFRACTION10.7TORSIONAL
22C1962X-RAY DIFFRACTION10.7TORSIONAL
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 14

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all% reflection obs (%)
2-2.050.32461410.273726442785100
2.05-2.10540.31861400.263525822722100
2.1054-2.16740.28271360.245325852721100
2.1674-2.23730.4051230.34852421254492
2.2373-2.31730.41741170.32672339245688
2.3173-2.410.26031370.215626442781100
2.41-2.51970.25921270.20726332760100
2.5197-2.65250.26541410.226262767100
2.6525-2.81860.26411420.202126302772100
2.8186-3.03620.25871310.205626552786100
3.0362-3.34150.2691250.196826672792100
3.3415-3.82450.25121430.181426772820100
3.8245-4.81660.20181660.149726762842100
4.8166-35.73510.19981530.165727992952100
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL11 (°2)L12 (°2)L13 (°2)L22 (°2)L23 (°2)L33 (°2)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T11 (Å2)T12 (Å2)T13 (Å2)T22 (Å2)T23 (Å2)T33 (Å2)Origin x (Å)Origin y (Å)Origin z (Å)
10.7406-0.5149-0.26320.5650.51880.7667-0.0996-0.1943-0.2657-0.1395-0.03280.55140.5077-0.4938-0.16190.251-0.1778-0.06530.34630.01850.373-2.547115.1356-16.4717
20.50740.0599-0.34240.1344-0.08130.23180.1045-0.36570.10220.3341-0.1380.14570.3377-0.32450.00150.2445-0.08170.02630.2866-0.06630.276110.289917.48545.7683
30.12320.04680.02940.3727-0.53890.8092-0.0317-0.07610.0168-0.1114-0.1711-0.07980.14780.064300.2381-0.00570.01980.19550.0030.284713.811113.8799-9.9826
4-0.0009-0.00050.00580.5352-0.46070.43820.00230.11410.22190.3003-0.2643-0.0702-0.4901-0.31-0.05060.3580.10290.00060.4228-0.14960.41168.90932.44847.5425
50.1217-0.0603-0.07580.07810.08650.09550.2122-0.18250.19920.12840.06570.0994-0.40230.14140.00470.3436-0.08-0.0670.27880.05090.454115.599533.1139-2.8838
60.25580.32660.13420.5041-0.02190.34-0.14050.34650.4239-0.07460.0787-0.24740.13910.1239-0.00070.22120.02030.01360.2506-0.00170.261112.09718.4535-14.9687
70.2797-0.0480.14660.1819-0.18550.371-0.20860.05840.4328-0.56120.02820.06870.0526-0.01250.0030.3691-0.0121-0.05120.27120.00540.39386.091122.8649-22.5603
80.071-0.1005-0.04010.13550.11910.1191-0.2303-0.02830.4450.0318-0.1563-0.2318-0.24540.2226-0.00570.3235-0.0279-0.06060.36120.02870.507918.735626.3252-9.4614
90.0456-0.09160.0040.25140.03930.1313-0.0721-0.28080.3624-0.2861-0.0757-0.23450.2816-0.13540.00460.3347-0.036-0.08510.3144-0.03880.442725.454219.496810.267
100.0366-0.01460.03440.02140.01180.08560.25630.01120.06830.0886-0.024-0.26020.27920.53450.00260.3320.00380.05860.27440.0560.460423.807911.67840.3523
110.0373-0.11440.13660.3641-0.38280.54580.35890.1209-0.2602-0.0281-0.2425-0.53130.80040.1632-0.00030.3723-0.0523-0.00780.22630.03150.337619.041.3756-5.5741
120.06610.02820.03290.2019-0.0220.1358-0.05040.0204-0.14060.10390.2051-0.03780.06590.3683-0.00020.4670.1810.02210.3632-0.02720.352830.767339.661927.0667
130.27120.1719-0.17620.3364-0.13740.3621-0.3188-0.7591-0.23510.70860.1024-0.18360.31180.5528-0.00480.48650.18820.08120.50080.06720.249419.193751.227646.965
140.0417-0.02170.02550.20080.25340.6115-0.2401-0.1072-0.00080.22070.135-0.10160.07320.228800.2930.09360.02510.37110.00640.28427.162355.897533.192
150.03470.0679-0.08530.1329-0.15660.1672-0.1018-0.0933-0.1259-0.0316-0.1382-0.02850.3716-0.0501-2.16230.29490.14260.57910.2234-0.09120.00854.953147.505843.9073
160.43340.1930.40450.43620.08480.4962-0.135-0.05540.2240.0960.04870.00950.1876-0.2347-00.2630.04930.05020.3437-0.00570.255917.385853.579629.7431
170.2113-0.1310.05870.1539-0.10930.3754-0.25590.3622-0.0087-0.54620.16190.18350.06310.1004-0.00180.34140.03990.04210.3237-0.0120.307624.319446.845318.6787
180.1852-0.0712-0.07150.06840.00780.0704-0.0504-0.03420.0925-0.1574-0.03160.0857-0.1966-0.1426-0.0010.34920.09980.02570.3440.01240.279814.148458.609729.5255
190.0861-0.10740.10050.2398-0.19220.1546-0.1091-0.13270.41410.7343-0.26620.2683-0.27920.1002-0.02440.45540.09830.04190.6121-0.08280.445312.284265.338149.9745
200.2108-0.1771-0.08010.19670.05660.06820.5258-0.00010.2098-0.59230.5662-0.1309-0.27390.36550.00490.49950.0279-0.01970.7144-0.03020.358823.955665.87243.5728
211.84760.3204-0.44180.5179-0.42160.3683-0.0231-0.04710.425-0.08260.03780.0743-0.61170.29970.05860.43910.0426-0.14530.7652-0.02680.349337.10261.702341.2231
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection detailsAuth asym-IDAuth seq-ID
1X-RAY DIFFRACTION1chain 'A' and (resid 247 through 266 )A247 - 266
2X-RAY DIFFRACTION2chain 'A' and (resid 267 through 307 )A267 - 307
3X-RAY DIFFRACTION3chain 'A' and (resid 308 through 341 )A308 - 341
4X-RAY DIFFRACTION4chain 'A' and (resid 342 through 362 )A342 - 362
5X-RAY DIFFRACTION5chain 'A' and (resid 363 through 379 )A363 - 379
6X-RAY DIFFRACTION6chain 'A' and (resid 380 through 404 )A380 - 404
7X-RAY DIFFRACTION7chain 'A' and (resid 405 through 432 )A405 - 432
8X-RAY DIFFRACTION8chain 'A' and (resid 433 through 456 )A433 - 456
9X-RAY DIFFRACTION9chain 'A' and (resid 457 through 466 )A457 - 466
10X-RAY DIFFRACTION10chain 'A' and (resid 467 through 476 )A467 - 476
11X-RAY DIFFRACTION11chain 'B' and (resid 745 through 755 )B745 - 755
12X-RAY DIFFRACTION12chain 'C' and (resid 247 through 266 )C247 - 266
13X-RAY DIFFRACTION13chain 'C' and (resid 267 through 307 )C267 - 307
14X-RAY DIFFRACTION14chain 'C' and (resid 308 through 341 )C308 - 341
15X-RAY DIFFRACTION15chain 'C' and (resid 342 through 362 )C342 - 362
16X-RAY DIFFRACTION16chain 'C' and (resid 363 through 404 )C363 - 404
17X-RAY DIFFRACTION17chain 'C' and (resid 405 through 432 )C405 - 432
18X-RAY DIFFRACTION18chain 'C' and (resid 433 through 456 )C433 - 456
19X-RAY DIFFRACTION19chain 'C' and (resid 457 through 466 )C457 - 466
20X-RAY DIFFRACTION20chain 'C' and (resid 467 through 476 )C467 - 476
21X-RAY DIFFRACTION21chain 'D' and (resid 746 through 755 )D746 - 755

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more